NephroCheck is measuring the concentration of a certain protein combination in the urine of patients. In elevated values there is a probability of renal failure (already proven in intensive care patients). The investigators would like to investigate whether the investigators can predict renal failure in patients receiving contrast enhanced CT's in the emergency department. That would lead to an earlier nephrologist consult in those patients.
The use of contrast agents can - especially in already in impaired renal function - lead to a decline in real function. The contrast enhanced CT is especially in emergency patients an important diagnostic tool for example in the detection of pulmonary embolism or mesenteric ischemia. Creatinine has been used as a marker for real function so far. But the investigators all know that creatinine is not a perfect marker especially as it is influenced by age, sex, weight and muscle mass. Especially in the diagnosis of acute renal failure creatinine does not allow and recent change in the kidney function. This prospective, unicentric study should therefore investigate two new markers in emergency patients who need an emergency contrast enhanced CT to early predict pending kidney function decline.
Study Type
OBSERVATIONAL
Krankenhaus Barmherzige Brueder
Regensburg, Bavaria, Germany
Renal function
renal function at discharge from hospital (creatinine and BUN measured at day of discharge)
Time frame: participants will be followed for the duration of hospital stay, an expected average of 7 days
Requirement for dialysis
dialysis required throughout hospital stay
Time frame: participants will be followed for the duration of hospital stay, an expected average of 7 days
Admission to ICU
admission to ICU required throughout hospital stay
Time frame: participants will be followed for the duration of hospital stay, an expected average of 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.